Company Valuation: IDEXX Laboratories, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 55,833 33,786 46,098 33,854 54,022 46,935 - -
Change - -39.49% 36.44% -26.56% 59.57% -13.12% - -
Enterprise Value (EV) 1 56,612 35,022 46,592 34,434 54,690 47,303 46,837 46,038
Change - -38.14% 33.04% -26.09% 58.83% -13.51% -0.98% -1.71%
P/E 76.6x 50.8x 55.2x 38.7x 51.7x 40.3x 35.7x 31.5x
PBR 82.6x 55.6x 31x 21.6x 34.1x 23.4x 17.1x 12.4x
PEG - -7.66x 2.2x 6.38x 2.3x 3.1x 2.7x 2.4x
Capitalization / Revenue 17.4x 10x 12.6x 8.69x 12.6x 9.93x 9.13x 8.38x
EV / Revenue 17.6x 10.4x 12.7x 8.83x 12.7x 10x 9.11x 8.22x
EV / EBITDA 54.6x 34.7x 38.4x 28.1x 36.3x 28.1x 25.3x 22.4x
EV / EBIT 60.7x 39x 42.5x 30.5x 40.2x 30.9x 27.7x 24.4x
EV / FCF 89x 88.9x 60.3x 42.6x 51.7x 40.3x 36.1x 31.7x
FCF Yield 1.12% 1.13% 1.66% 2.35% 1.93% 2.48% 2.77% 3.16%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 8.6 8.03 10.06 10.67 13.08 14.77 16.7 18.92
Distribution rate - - - - - - - -
Net sales 1 3,215 3,367 3,661 3,898 4,304 4,724 5,140 5,602
EBITDA 1 1,037 1,011 1,212 1,225 1,505 1,682 1,855 2,052
EBIT 1 932 898.8 1,097 1,128 1,360 1,529 1,693 1,888
Net income 1 744.8 679.1 845 887.9 1,059 1,179 1,314 1,473
Net Debt 1 779.2 1,236 493.9 579.3 667.8 368 -97.34 -896.8
Reference price 2 658.46 407.96 555.05 413.44 676.53 595.76 595.76 595.76
Nbr of stocks (in thousands) 84,794 82,817 83,052 81,885 79,851 78,781 - -
Announcement Date 02/02/22 06/02/23 05/02/24 03/02/25 02/02/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. IDXX Stock
  4. Valuation IDEXX Laboratories, Inc.